MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Income Overview

Net Income
-$53,146,000
EPS
-$1.74
Unit: Dollar

Income Statement
2026-06-30
2026-03-31
Collaboration revenue
0 0
Research and development
36,226,000 32,321,000
General and administrative
10,511,000 7,350,000
Change in fair value of contingent consideration
8,733,000 109,000
Total operating expenses
55,470,000 39,780,000
Operating loss
-55,470,000 -39,780,000
Interest income
2,832,000 1,708,000
Interest expense
20,000 10,000
Other expense, net
-138,000 -117,000
Total other income, net
2,674,000 1,581,000
Loss before income taxes
-52,796,000 -38,199,000
Income tax provision
-8,000 63,000
Net loss
-52,788,000 -38,262,000
Foreign currency translation adjustment
113,000 -306,000
Unrealized gain (loss) on marketable securities, net of tax
-471,000 -86,000
Total other comprehensive (loss) income
-358,000 -392,000
Comprehensive loss
-53,146,000 -38,654,000
Basic EPS
-1.74 -6.77
Diluted EPS
-1.74 -6.77
Basic Average Shares
30,277,051 5,655,716
Diluted Average Shares
30,277,051 5,655,716
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

Comprehensive loss-$53,146,000 Net loss-$52,788,000 Total othercomprehensive (loss) income-$358,000 Income tax provision-$8,000 Foreign currencytranslation adjustment$113,000 Interest income$2,832,000 Loss before incometaxes-$52,796,000 Unrealized gain (loss) onmarketable securities, net...-$471,000 Total other income,net$2,674,000 Other expense, net-$138,000 Interest expense$20,000 Operating loss-$55,470,000 Total operatingexpenses$55,470,000 Research and development$36,226,000 General andadministrative$10,511,000 Change in fair value ofcontingent consideration$8,733,000

Odyssey Therapeutics, Inc. (ODTX)

Odyssey Therapeutics, Inc. (ODTX)